Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis

The SF-36 has some limitations as an outcome measure in multiple sclerosis. The results highlight the need for all instruments to be examined in the specific sample population under question and for the specific research question being investigated. In multiple sclerosis clinical trials, the SF-36 should be supplemented with other relevant measures.